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Purpose: To isolate fibroblast precursors from rabbit corneal stroma using a sphere-forming assay, to engineer corneal
stroma with the precursors and gelatin, and to establish the therapeutic application of precursors in a rabbit corneal stroma.
Methods: In the in vitro study, a sphere-forming assay was performed to produce precursors from rabbit corneal stroma.
Corneal stroma was engineered by cultivating precursors in porous gelatin for one week. In the in vivo study, the engineered
corneal stromal sheet with precursors (precursor/gelatin group) or with fibroblasts (fibroblast /gelatin group) or without
cells (gelatin group) was transplanted to a pocket of rabbit corneal stroma. Gene expression and extracellular matrix
production were examined immunohistochemically in each group one week and four weeks after surgery.
Results: In the in vitro study, cells in the spheres were BrdU-positive, and their progeny were keratocan-positive. The
study also showed that the corneas transplanted with a porous gelatin sheet did not show any opacity four weeks after
transplantation in any group. In the gelatin sheet of the precursor/gelatin group, a more intense expression of type I collagen
was observed relative to the other two groups four weeks after the surgery.
Conclusions: Our findings demonstrate that the transplantation of fibroblast precursors combined with gelatin hydrogel
into the corneal stroma is a possible treatment strategy for corneal stromal regeneration.
Although corneal transplantation has achieved clinical
success, there is a shortage of corneal donors worldwide. To
solve  this  problem,  researchers  have  attempted  to  tissue-
engineer  the  cornea.  Among  the  three  components  of  the
cornea  (epithelium,  stroma,  and  endothelium),  tissue-
engineered  corneal  epithelial  cell  sheets  have  been  used
clinically to create the corneal epithelium in patients with total
limbal stem cell deficiencies [1-4]. Tissue-engineered corneal
endothelial  cell  sheets  have  successfully  restored  corneal
transparency in animal models [5-10] and are ready to be used
in clinical cases. In contrast, none of tissue-engineered corneal
stroma have been deemed clinically feasible, although several
kinds of tissue-engineered corneal stroma have been reported
[11].
For  successful  tissue  engineering,  stem  cells  and
progenitor  or  precursor  cells,  which  possess  proliferative
capacity  and  multilineage  developmental  potential,  are
proposed to be an effective cell source. Regenerative stem
cells or precursors can be detected in various adult tissues with
a sphere-forming assay, including the central nervous system
[12], bone marrow [13], skin [14,15], retina [16], and corneal
endothelium [8-10,17-20]. Stem and progenitor cells retain
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their regenerative potential and may promote rapid wound
healing compared with differentiated fibroblasts after they are
transplanted  to  recipients.  The  use  of  adult  stem  cells  or
precursors presents an ideal strategy for tissue regeneration
and engineering [21]. Despite these many successes in the
isolation  and  characterization  of  stem  cells  from  various
tissues, relatively few studies have investigated the efficacy
of stem cell transplantation therapy. Using a sphere assay, we
succeeded in isolating precursor cells from human and rabbit
corneal stroma [20,22,23]. In this study, we have constructed
a substitute for corneal stroma using fibroblast precursors and
porous gelatin hydrogels in vitro by tissue engineering and
have  investigated  the  feasibility  of  transplantation  of  the
engineered corneal stroma in a rabbit model.
METHODS
Sphere-forming assay: Rabbits were treated in accordance
with  the  ARVO  Statement  on  the  Use  of  Animals  in
Ophthalmic  and  Vision  Research.  Sixteen  corneas  were
excised  from  eyes  of  eight  New  Zealand  White  rabbits
weighing 2.0–2.4 kg (Saitama Experimental Animals Inc.,
Saitama, Japan) under deep anesthesia. The entire corneal
epithelium and endothelium with Descemet’s membrane were
mechanically removed. The stroma was cut into small pieces
approximately  1.0  mm  in  diameter  and  the  pieces  were
incubated overnight at 37 °C in basal medium containing
0.02%  collagenase  (Sigma-Aldrich,  St.  Louis,  MO).
Subsequently, the tissue pieces were dissociated into single
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1819cells with 0.2% EDTA. Dissociated single cells were used for
sphere-forming  assay  or  culture  of  fibroblast.  The  basal
medium  was  composed  of  Dulbecco’s  modified  Eagle’s
medium (DMEM)/F12 supplemented with B27 (Invitrogen,
Carlsbad,  CA),  20  ng/ml  epidermal  growth  factor  (EGF;
Sigma-Aldrich), and 40 ng/ml basic fibroblast growth factor
(bFGF; Sigma-Aldrich). The sphere-forming assay was used
for primary cell culture [24,25]. Cells were cultured in the
basal medium containing a methylcellulose gel matrix (0.8%;
Wako, Osaka, Japan) at a density of 10 viable cells/μl in the
uncoated  wells  of  60  mm  culture  dishes.  For  passaging,
primary spheres (collected on day 7) were dissociated into
single cells with 0.5% EDTA, and cells were cultured at a
density  of  10  cells/μl  in  basal  medium  containing  0.8%
methylcellulose.
Differentiation of sphere colonies: Individual primary spheres
(collected  on  day  7)  were  transferred  to  13  mm  glass
coverslips coated with 50 μg/ml poly-L-lysine (PLL; Sigma-
Aldrich,  Tokyo,  Japan)  and  10  μg/ml  fibronectin  (BD
Biosciences, Billerica, MA) after each glass coverslip was put
in 24 wells. To promote differentiation, 1% fetal bovine serum
(FBS) was added to the basal medium, and the culture was
continued for another seven days.
Culture  of  corneal  fibroblast:  Isolated  fibroblasts  were
counted with a hemocytometer. Dissociated single primary
fibroblasts were plated at a density of 5.0×104 cells/ml in a 60
mm  tissue  culture  dish  and  cultured  in  DMEM  (Sigma-
Aldrich) supplemented with 10% FBS (Sigma-Aldrich) for
seven days.
Immunocytochemistry of keratocan in spheres and progenies:
Immunocytochemical examination of the seven-day spheres
and their progeny was performed after seven days of adherent
culture on the glass coverslips. Cells were fixed with 4%
paraformaldehyde (Wako Pure Chemical Industries, Osaka,
Japan) in phosphate-buffered saline (PBS) for 10 min. After
washing in PBS, the cells were incubated for 30 min with 3%
bovine serum albumin (BSA; Sigma-Aldrich) in PBS, which
contained 0.3% Triton X-100 (BSA/TBST; Rohm & Haas,
Philadelphia, PA) to block nonspecific binding. Next, the cells
were incubated for 2 h at room temperature with the following
primary antibodies diluted in BSA/PBST: goat anti-keratocan
polyclonal antibody (1:400; Santa Cruz Biotechnology, Santa
Cruz,  CA)  and  FITC-conjugated  mouse  anti-5-bromo2’-
deoxyuridine  (BrdU)/fluorescence  mAb  (1:100;  Roche
Diagnostics, Basel, Switzerland). After being washed in PBS,
the  cells  were  reacted  for  1  h  at  room  temperature  with
fluorescence-labeled goat anti-rabbit IgG (Alexa Fluor 594,
1:400;  Molecular  Probes,  Eugene,  OR)  as  the  secondary
antibodies  for  the  anti-keratocan  antibody.  Finally,
fluorescence  was  detected  by  observation  under  a
fluorescence microscope (model BH2-RFL-T3 and BX50;
Olympus, Tokyo, Japan).
Preparation of gelatin hydrogels and electron microscopic
observation: Porous gelatin hydrogels were prepared through
the chemical cross-linking of aqueous gelatin solution with
glutaraldehyde according to the method described elsewhere
[26,27].  Briefly,  an  aqueous  gelatin  solution  mixed  with
glutaraldehyde was cast into a polypropylene dish followed
by the cross-linking reaction at 4 °C for 12 h. The hydrogel
samples were stirred in 100 mM aqueous glycine solution at
37  °C  for  1  h  and  washed  with  double-distilled  water.
Following the washing with sterilized saline, the hydrogel
samples were trephined with a 5.0 mm diameter trephine (Kai
Medical, Gifu, Japan). The structure of the gelatin hydrogel
was observed using scanning electron microscopy.
Sphere or fibroblast seeding onto gelatin hydrogels and cell
culture: Ten primary fibroblast spheres (50 μm or more in
diameter) cultured for seven days or 100,000 primary cultured
fibroblasts were applied to the gelatin hydrogels after which
the gelatin hydrogels were placed in 5.0 mm diameter wells
and centrifuged at 1,000 rpm (176x g) for 10 min to promote
the  attachment  of  cells  to  gelatin  hydrogels.  The  tissue-
engineered samples were then maintained in the basal medium
containing 10% FBS in a 24 well culture dish for seven days
after which the medium containing debris was removed. The
primary  spheres  (50  μm  of  the  diameter)  contained
approximately  300  cells.  In  some  experiments,  primary
spheres were labeled with a fluorescent cell tracker (CM-DiI;
C-7000;  Molecular  Probes)  to  trace  their  localization  as
described elsewhere [7].
Transplantation of gelatin hydrogels with corneal fibroblast
precursors: A lamellar dissection was made in 24 eyes of 24
rabbits (Figure 1A,B). The engineered corneal stroma was
implanted into a mid-stroma corneal pocket without suture
fixation. Twenty-four rabbits were divided into three groups,
the gelatin group (n=8) transplanted with gelatin hydrogels
alone, the fibroblast/gelatin group (n=8) transplanted with
fibroblasts cultured on gelatin hydrogels, and the precursor/
gelatin group (n=8) transplanted with fibroblast precursors
cultured on gelatin hydrogels.
Histological  examination  and  immunohistochemistry  of
extracellular matrix: One week (n=2 in each group) or four
weeks (n=6 in each group) after transplantation, the rabbits
were sacrificed with an overdose of intravenous pentobarbital
sodium  (Dainippon  Pharmaceutical,  Osaka,  Japan).  Each
cornea was excised and bisected. The divided corneas or the
seven-day cultured gelatin hydrogel sheets for transplantation
were  fixed  in  4%  paraformaldehyde,  embedded  in  OCT
compound (Tissue-Tek®; Miles Laboratories, Naperville, IL),
and then frozen at −20 °C. Cryostat sections were cut into
pieces 6 µm thick and stained with hematoxylin and eosin. For
immunohistochemical staining, the sections were treated with
3% hydrogen peroxide in PBS (Sigma-Aldrich) for 15 min
and then rinsed in PBS. After incubation with normal goat
serum for 10 min at room temperature, tissue sections were
incubated with primary antibodies (goat anti-rabbit type I
collagen, type IV collagen, laminin, and vimentin polyclonal
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1820antibodies; all from Santa Cruz Biotech) at a concentration of
3 μg/ml overnight at 4 °C. Immunoreactivity was detected by
the streptavidin-biotin-peroxidase method using a Histofine
SAB-PO kit (Nichirei Corporation, Tokyo, Japan). The final
reaction product was visualized using 3,3′-diaminobenzidine
tetrahydrochloride.
Immunohistochemistry of CD34 and nestin: In the precursor/
gelatin group, frozen sections (8 μm) were stained with mouse
anti-CD34  mAb  (1:100;  Novocastra  Laboratories  Ltd.,
Newcastle upon Tyne, UK) or mouse anti-nestin mAb (1:400;
BD Biosciences, San Jose, CA) for 2 h and incubated with
fluorescence-labeled goat anti-mouse IgG (Alexa Fluor 488,
1:200; Molecular Probes) for 30 min at room temperature.
After  several  washings  with  PBS,  the  sections  were
coverslipped  using  anti-fading  mounting  medium
(Vectashield;  Vector  Laboratories,  Burlingame,  CA)  and
were observed under the fluorescein microscope.
RESULTS
Isolation of sphere colonies and secondary sphere formation:
Corneal stroma was disaggregated into single cells, which
were cultured for seven days. A photograph of a representative
sphere is shown in Figure 2A. Many cells within the sphere
colonies  were  positive  for  BrdU,  indicating  active  DNA
synthesis  (Figure  2B).  The  cells  from  primary  spheres
primarily differentiated into fibroblast-like cells (Figure 2C).
Secondary spheres were generated from dissociated primary
spheres  (Figure  2D).  The  primary  spheres’  diameters  are
larger than those of the secondary spheres as shown in Figure
2A,D. Additionally, replating to generate secondary sphere
colonies was less efficient than the generation of primary
spheres [23]. These results indicate that the precursor cells had
a limited proliferative capacity.
Immunocytochemical  analysis  of  extracellular  matrix  in
gelatin  hydrogels:  Scanning  electron  microscopy
demonstrated  porous  structure  of  the  gelatin  hydrogels
(Figure 3A). Corneal fibroblasts or fibroblast precursors were
Figure 1. Schematic illustration and clinical findings. A: Fibroblast precursors were isolated from the rabbit corneal stroma using a sphere-
forming assay. Corneal stroma was engineered by cultivating precursors in porous gelatin for one week. The engineered corneal stromal sheet
with precursors was transplanted in a pocket of rabbit corneal stroma. B,C: Gelatin hydrogels (gelatin group), gelatin hydrogels with corneal
fibroblasts (fibroblast/gelatin group), or gelatin hydrogels with corneal fibroblast precursors (precursor/gelatin group) were implanted into
the corneal stroma (indicated by arrows in C). D-F: Representative photographs of corneas four weeks after transplantation in each group are
shown. No corneal opacity and no rejection were observed in any group four weeks after transplantation (indicated by dotted white circles in
D-F).
Molecular Vision 2008; 14:1819-1828 <http://www.molvis.org/molvis/v14/a215> © 2008 Molecular Vision
1821cultured on porous gelatin hydrogels for seven days, and the
expression of vimentin, a marker of mesenchymal cells, as
well  as  extracellular  matrix  (ECM)  production  were
evaluated. The positive staining with vimentin suggests that
the progenitor cells were not converted into inflammatory
cells. Vimentin expression was more intense in porous gelatin
hydrogels with fibroblast precursors than it was in those with
corneal fibroblasts (Figure 3B). Weak expression of laminin
was  also  seen  in  the  gelatin  hydrogels  with  fibroblast
precursors while no expression was observed in those with
corneal fibroblasts (Figure 3B). Little expression of types I
and IV collagen was detected in the porous gelatin hydrogels
with corneal fibroblasts or fibroblast precursors (Figure 3B).
Clinical observation after surgery: The therapeutic use of
precursors derived from corneal fibroblasts was investigated
in  a  rabbit  model  (Figure  1A-C).  As  shown  in  the
representative anterior segment photographs from the gelatin
group (transplanted with gelatin hydrogels alone, Figure 1D),
the  fibroblast/gelatin  group  (transplanted  with  gelatin
hydrogels  with  corneal  fibroblasts,  Figure  1E),  and  the
precursor/gelatin group (transplanted with gelatin hydrogels
with corneal fibroblast precursors, Figure 1F), the corneas
were clear and showed no edema and no cell infiltration of the
stroma  in  all  of  the  groups.  No  apparent  immunological
reactions were observed during the follow-up period. No side
effects including an increase in intraocular pressure, corneal
neovascularization, corneal ulcer, or corneal infection were
detected during the observation period.
Histological examination and analysis of extracellular matrix
production with immunohistochemistry:  The corneas were
excised from the eyes either one week or four weeks after
transplantation.  The  expressions  of  vimentin  and  ECM
molecules  such  as  laminin,  type  I  collagen,  and  type  IV
collagen were more intense in the precursor/gelatin group than
the other groups after one week (Figure 4A). Their expression
increased  after  four  weeks  in  the  precursor/gelatin  group
(Figure 4B).
Expression of progenitor cell markers in the transplanted
gelatin hydrogels: We examined the expression of CD34,
which is a well known hematopoietic stem/progenitor cell
marker and is also expressed by all differentiated keratocytes
[28],  and  nestin,  a  neural  progenitor  cell  marker  in  the
precursor/gelatin  group,  four  weeks  after  transplantation.
Many CD34-positive cells were detected in and around the
transplanted gelatin hydrogels (Figure 5A). Nestin-positive
cells were also observed in the transplanted gelatin hydrogels
(Figure 5B). No CD34-positive or nestin-positive cells were
seen in the other groups in the transplanted gelatin hydrogels
(data not shown).
DISCUSSION
We established the therapeutic application of precursors in a
rabbit corneal stroma using fibroblast precursors and gelatin
hydrogels as the substitute carrier of corneal stroma. Cultured
precursors  derived  from  adult  rabbit  stroma  retain  the
essential  fibroblast  morphology.  The  transplanted  gelatin
Figure 2. Sphere formation from rabbit corneal fibroblasts. A: A representative day 7 sphere from rabbit corneal fibroblasts had a diameter
of approximately 300 μm. B: Each primary sphere was positive for BrdU on day 7. C: The differentiated progeny from the primary sphere
showed a typical fibroblast-like morphology. D: Secondary spheres were generated from dissociated primary spheres. E and F: Day 7 spheres
were positive for keratocan. G and H: Progenies derived from the sphere are positive for keratocan. Scale bar=100 μm.
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1822hydrogels with fibroblast precursors induced the production
of ECM by the host stroma.
Adult vertebrate corneal stroma is composed primarily of
collagen  type  1  fibrils,  smaller  amounts  of  other  ECM
proteins, and keratocytes. Therefore, both cells and a stratified
complex of the ECM, which form a scaffold for precursors,
are necessary to engineer a three-dimensional corneal stroma.
Porous scaffolds used in tissue engineering contribute to cell
proliferation and differentiation in a suitable environment as
well as the maintenance of structure and composition in the
injured  tissues.  Furthermore,  three-dimensional  porous
scaffolds  provide  a  larger  surface  for  cell  attachment,
migration, and proliferation compared with two-dimensional
scaffolds, which facilitate contact inhibition in confluent cells.
Because  corneal  fibroblast  proliferation  is  substrate-
dependent, it is preferable to increase the surface area of the
culture substrate. Several three-dimensional substrates such
as collagen have been designed to demonstrate their capacity
for proliferative enhancement [29-31]. Their long-term safety,
stability,  and  efficacy  in  vivo  have  been  adequately
established in humans. However, the significant drawback of
collagen is its poor biodegradation and bioabsorption. The
biodegradation of biomaterials and their biocompatibility are
probably their most desired properties because the insoluble
biomaterials develop biological reactions in vivo resulting in
tissue opacity. Gelatin, a denatured type of collagen, possesses
Figure 3. Immunohistochemical analysis of extracellular matrix in porous gelatin hydrogels with corneal fibroblasts or fibroblast precursors.
Corneal fibroblasts or fibroblast precursors were seeded onto porous gelatin hydrogels and cultured for one week. A: Scanning electron
microscopy revealed a porous structure for the gelatin hydrogels. B: Hematoxylin and eosin staining and immunohistochemical analysis of
vimentin and ECM in porous gelatin hydrogels seven days after seeding of corneal fibroblasts or fibroblast precursors are shown. Vimentin
staining was more intense in the gelatin hydrogels with corneal fibroblast precursors than in those with corneal fibroblasts (arrows). Other
ECM components such as laminin, type I collagen, and type IV collagen are not expressed in the gelatin hydrogels with corneal fibroblasts
or fibroblast precursors before transplantation except for a weak expression of laminin in the gelatin hydrogels with corneal fibroblast
precursors (arrow). Scale bar=200 μm in B.
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1823Figure 4. Histological findings and immunocytochemical analysis of extracellular matrix at one week and four weeks after transplantation.
The transplanted gelatin hydrogels are found in the corneal stroma in all groups. H&E staining reveals no mononuclear cell infiltration around
gelatin hydrogels in all groups. The precursor/gelatin group shows more intense staining of laminin, type I collagen, type IV collagen, and
vimentin in the transplanted gelatin than in the gelatin and fibroblast/gelatin groups one week after transplantation (A). These expressions in
the precursor/gelatin group increase four weeks after transplantation (B). Scale bar=100 μm.
Molecular Vision 2008; 14:1819-1828 <http://www.molvis.org/molvis/v14/a215> © 2008 Molecular Vision
1824most of the properties of an ideal scaffold and has been applied
clinically  as  an  implant  material  [32].  We  used  a
biodegradable porous gelatin hydrogel, which is effective in
facilitating cell migration and the delivery of oxygen and
nutrients to the migrated cells, as a carrier of corneal fibroblast
precursors. In the previous in vivo degradation tests in the
conjunctival sac of mice, the residual radioactivity in carrier
gels ranged from 50.7% to 54.7% on day 1 and from 11.2%
to 18.4% on day 7. [33]. In monkey skull defect models, the
gelatin hydrogel with a water content of 93.8 wt% did not
degrade and remained at the skull defect site 12 weeks after
application [34]. In the current study, the hydrogel did not
degrade in the corneal stroma four weeks after transplantation.
The rate of hydrogel degradation in the corneal stroma may
be slow compared with those of the conjunctival sac of mice
and skull defect models of the monkey.
Each  primary  sphere  (50  μm  in  diameter)  contained
approximately  300  cells.  Therefore  10  spheres  contain
approximately  3,000  cells.  Despite  the  total  cell  number
within 10 corneal fibroblast spheres being approximately 30
fold less than 100,000 corneal fibroblasts, the porous gelatin
hydrogels  that  incorporated  10  corneal  fibroblast  spheres
cultured  ex  vivo  for  seven  days  showed  more  intense
immunostaining  for  vimentin  than  those  incorporating
100,000 corneal fibroblasts cultured for seven days, which
indicates that the corneal fibroblast precursors had superior
proliferative potential on the gelatin hydrogels compared with
corneal fibroblasts. Where weak expression of laminin and
collagens were detected in gelatin hydrogels that incorporated
corneal fibroblasts precursors, these ECM components were
barely detected in the gelatin incorporating corneal fibroblasts
ex vivo before transplantation. These results indicate that the
gelatin  hydrogel  itself  had  no  ability  to  induce  tissue
regeneration in vitro or ex vivo.
We have previously produced spheres from human [22]
and rabbit [23] corneal stroma. The individual spheres and
their progeny expressed mesenchymal and neuronal lineage
marker  proteins.  Moreover,  they  expressed  keratocan  that
were used as keratocyte-specific markers [35-37], suggesting
that fibroblast progenitors and progenies have an essential
lineage of keratocytes. Immunohistochemical findings on day
7 and 28 showed that the expression of type I collagen, type
IV collagen, laminin, and vimentin were strongly positive in
the transplanted gelatin hydrogels of the precursor/gelatin
group while they were faint in the gelatin and fibroblast/
gelatin groups. Gelatin hydrogels alone function to induce
ECM production to some extent in vivo, but the efficacy is not
as high as that of the gelatin hydrogels with precursors.
In the ex vivo experiments, the expression of ECMs were
low in all groups while the in vivo experiments showed that
vimentin expression in transplanted gelatin hydrogels was
higher in precursor/gelatin groups compared with the other
two groups. In Figure 4A, the corneal stroma as a whole (even
tissue far away from the transplanted tissue) had stronger
expression  of  vimentin  and  ECM  in  the  precursor/gelatin
group than the other groups. Also in Figure 4A, vimentin
expression in the gelatin group was stronger than that in the
Figure 5. Immunolocalization of CD34-positive or nestin-positive cells within the transplanted DiI-positive precursors in the precursor/gelatin
group four weeks after transplantation of gelatin hydrogels with corneal fibroblast precursors. Bright light (black and white, background),
rhodamine (red, the transplanted DiI-labeled corneal fibroblast precursors in the gelatin hydrogels), and FITC (green, CD34- or nestin-positive
cells) are superimposed with Adobe Photoshop software. Whole transplanted gelatin hydrogels are shown in light red by many DiI-positive
corneal fibroblast precursors. A few CD34-positive cells or nestin-positive spindle cells are scattered within the gelatin hydrogels. Scale
bar=100 μm.
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1825fibroblast/gelatin  group.  These  suggest  that  ECM  and
vimentin arise from the host and not the transplanted cells.
Furthermore, expression of ECM and vimentin increased
four weeks after transplantation in all groups compared with
just one week. The gelatin only also promotes ECM secretion.
Both precursors and gelatin may promote the production of
ECM derived from the host stroma and not the transplanted
cells.
Immunofluorescence  microscopy  of  the  precursor/
gelatin group on day 28 revealed that the CD34-positive cells
and nestin-positive cells were localized to the transplanted
gelatin hydrogels. This indicates that fibroblast precursors
with a greater self-renewal potential continue to proliferate
even  after  transplantation  and  can  supply  fibroblasts
necessary for the regeneration of the host stroma. The nestin-
positive  cells  may  also  contribute  to  induction  of  nerve
regeneration.
The  combined  transplantation  of  corneal  fibroblast
precursors  with  gelatin  hydrogels  into  a  corneal  stromal
pocket has several advantages over penetrating keratoplasty
of full-thickness donor cornea. Most complications associated
with open-sky surgery such as expulsive hemorrhage and the
risks  of  wound  dehiscence  would  be  eliminated.  Several
postoperative complications such as a postoperative corneal
irregular  astigmatism,  wound  leakage,  corneal  infection,
vascularization,  and  persistent  epithelial  defect  can  be
avoided. Allograft rejection is a leading cause of the failure
of conventional full thickness corneal allografting with local
and/or  systemic  immunosuppressants.  Histologically,  no
apparent  inflammatory  reaction  including  immunological
rejection  was  detected  in  the  current  corneal  fibroblast
precursor allotransplantation. This finding suggests that the
transplanted  precursors  can  survive  in  the  corneal  stroma
without rejection.
One of the major limitations for clinical application of
corneal fibroblast precursor transplantation is the availability
of donor fibroblast precursors in sufficient quantities. This
study demonstrated that the required number of spheres per
cornea was 10 spheres to promote the expression of ECM. In
the human cornea, the number of digested stromal cells from
individual corneas was 1.1×105, and the number of spheres
grown  from  one  cornea  was  1,566±211  [22],  which  are
adequate quantities for transplantation. These results suggest
the  feasibility  of  transplantation  of  autologous  fibroblast
precursor derived from a small piece of stroma. The main
weakness of this study may be the relatively short observation
period. Further long-term investigation including side effects,
rejection,  corneal  opacity,  infection  incidence,  and
histological observation is necessary. Additionally, our tissue
engineering based on the ECMs, which were not abundant in
normal cornea, does not represent restoration of a true stromal
ECM. Further investigation is necessary to show stromal-
specific matrix molecules such as keratan sulfate or keratocan
in the transplanted gelatin hydrogels.
As for the in vivo physiologic function of the transplanted
cornea, we could not perform the corneal sensitivity test in the
animal  model  because  we  cannot  evaluate  the  subjective
corneal  sensitivity  of  an  animal  using  a  Cochet-Bonnet
esthesiometer,  which  is  the  only  corneal  sensitivity  test.
Although we had no idea of corneal stress test, we found that
all groups had no obvious corneal weakness and there was no
significant difference in intraocular pressure among the three
groups. As for corneal nerves in the host tissues, a microscopic
examination of the frozen section and a confocal microscopic
examination of whole mount cornea showed no distinguished
corneal nerve in the host cornea after transplantation because
it is generally difficult to observe the corneal nerve. Further
examinations  about  corneal  physiologic  function  after
precursor transplantation may be necessary.
In  summary,  we  established  a  method  for  three-
dimensional tissue engineering of the substitute for corneal
stroma  using  fibroblast  precursors  and  gelatin  hydrogels.
Corneal  fibroblast  precursors-based  corneal  stromal
regeneration combined with gelatin hydrogel is a promising
new  therapy  to  promote  fibroblast  adherence  and  ECM
deposition after corneal fibroblast precursor transplantation.
This therapeutic tissue engineering is applicable to any type
of  cell  in  regenerative  medicine.  The  transplantation  of
corneal fibroblast precursors into a corneal stromal pocket
proved to be a simple and effective treatment strategy for
corneal regeneration, which may replace conventional full-
thickness corneal grafting and compensate for the worldwide
shortage of donor corneas.
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